Amelia Rauter

Has grant

Associate Professor

Faculdade de Ciências da Universidade de Lisboa

Portugal

Research Interests

Explore related searches

Professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Amelia Rauter is an Associate Professor at Universidade de Lisboa, Faculdade de Ciências in Portugal. Her research areas focus on organic synthesis, antimicrobial resistance, and Alzheimer's disease therapy, with recent works including the synthesis of antibacterial prodrugs and nucleoside analogues. She also investigates carbohydrate-based drugs and has published studies on the biological evaluation of compounds related to acetylcholinesterase inhibition.

Recent Grants

Grant: Close

Metrology of Carbohydrates for Enabling European Bioindustries

Open Date: 2017-01-01

Close Date: 2020-12-01

Grant: Close

Metrology of Carbohydrates for Enabling European Bioindustries

Open Date: 2017-01-01

Close Date: 2020-12-31

Grant: Close

Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease

Open Date: 2014-10-01

Close Date: 2018-09-30

Grant: Close

Diagnostic and Drug Discovery Initiative for Alzheimers Disease

Open Date: 2014-10-01

Close Date: 2018-09-01

Grant: Close

LisbonLiving+: Innovative strategies for a healthy life and an active ageing in the Region of Lisbon

Open Date: 2014-02-10

Close Date: 2014-09-09

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (18)

Cleide Souza

University of Sheffield

UNITED KINGDOM

Amelia Rauter

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Synthesis of Alkyl Levulinates from α-Angelica Lactone Using Methanesulfonic Acid as a Catalyst: A Sustainable and Solvent-Free Route

Antibacterial Prodrugs to Overcome Bacterial Antimicrobial Resistance

Recent antibacterial carbohydrate-based prodrugs, drugs and delivery systems to overcome antimicrobial resistance

Nucleoside analogues: N-glycosylation methodologies, synthesis of antiviral and antitumor drugs and potential against drug-resistant bacteria and Alzheimer's disease

Synthesis, Biological Evaluation, and Docking Studies of Open-Chain Carbohydrate Amides as Acetylcholinesterase Inhibitors

Quantification of Hydrolytic Sugars from Eucalyptus globulus Bio-Oil Aqueous Solution after Thermochemical Liquefaction

Flavonoids as Promising Multitarget Agents in Alzheimer’s Disease Therapy

Revisiting Purine Nucleoside Cholinesterase Inhibitors - An Experimental Glycon Structure/Activity Relationship Study

Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect

Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation

C-Glucosylation as a tool for the prevention of PAINS-induced membrane dipole potential alterations

Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting AßoPrPC binding and downstream pathways

Collaborators (18)

Cleide Souza

Benjamin Partridge

Carmen Ortiz Mellet

Nuno M. Xavier

Jorge Medeiros

Rita Pereira

José G. Fernandez-Bolaños

Modesto de Candia

Ke Ning

Elisabete Lima

Vasco Cachatra

María Isabel Garcia Moreno

Adilson Freitas

Rui Galhano dos Santos

Karina Shimizu

Ivo Paulo

Cosimo Altomare

M. Isabel Ismael

Make your next move.

Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting AßoPrPC binding and downstream pathways